Glaukos Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US3773221029
USD
98.94
1.92 (1.98%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Globus Medical, Inc.
Sotera Health Co.
Haemonetics Corp.
Masimo Corp.
Merit Medical Systems, Inc.
Envista Holdings Corp.
Glaukos Corp.
Neogen Corp.
Lantheus Holdings, Inc.
Inari Medical, Inc.
QuidelOrtho Corp.

Why is Glaukos Corp. ?

1
With a growth in Operating Profit of 17.44%, the company declared Very Positive results in Jun 25
  • OPERATING CASH FLOW(Y) Highest at USD -20.62 MM
  • NET PROFIT(HY) Higher at USD -37.8 MM
  • ROCE(HY) Highest at -12.98%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Glaukos Corp. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Glaukos Corp. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Glaukos Corp.
-3.18%
-0.06
53.77%
S&P 500
18.81%
0.70
20.15%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
17.67%
EBIT Growth (5y)
6.46%
EBIT to Interest (avg)
-5.91
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.39
Sales to Capital Employed (avg)
0.52
Tax Ratio
0.59%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
8.76
EV to EBIT
-70.01
EV to EBITDA
-111.60
EV to Capital Employed
14.49
EV to Sales
10.78
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-20.70%
ROE (Latest)
-10.09%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

20What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD -21.63 MM

NET SALES(Q)

Highest at USD 143.12 MM

RAW MATERIAL COST(Y)

Fallen by -15.24% (YoY

NET PROFIT(Q)

Highest at USD -12.19 MM

-4What is not working for the Company
CASH AND EQV(HY)

Lowest at USD 552.47 MM

DEBTORS TURNOVER RATIO(HY)

Lowest at 5.99 times

OPERATING PROFIT(Q)

Lowest at USD -18.4 MM

EPS(Q)

Lowest at USD -2.32

Here's what is working for Glaukos Corp.

Net Sales
Highest at USD 143.12 MM and Grown
In each period in the last five periods
MOJO Watch
Near term sales trend is very positive

Net Sales (USD MM)

Operating Cash Flow
Highest at USD -21.63 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Sales
At USD 143.12 MM has Grown at 21.85%
over average net sales of the previous four periods of USD 117.45 MM
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Net Profit
Highest at USD -12.19 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

Net Profit
At USD -12.19 MM has Grown at 44.35%
over average net sales of the previous four periods of USD -21.9 MM
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

Raw Material Cost
Fallen by -15.24% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Glaukos Corp.

Operating Profit
Lowest at USD -18.4 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (USD MM)

EPS
Lowest at USD -2.32
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Cash and Eqv
Lowest at USD 552.47 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debtors Turnover Ratio
Lowest at 5.99 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio